Micro-structured hydroxyapatite microspheres for local delivery of alendronate and BMP-2 carriers
Source abstract
Abstract
Abstract This study describes the preparation of hydroxyapatite microspheres for local delivery of alendronate and BMP-2. The hydroxyapatite microsphere preparation was initiated by enzymatic decomposition of urea and accomplished using an emulsification process (water-in-oil) for nucleation and growth of hydroxyapatite within the microemulsion. The microspheres obtained were then sintered at 500 °C. Scanning electron microscope (SEM) indicated that the microspheres have particle-in-sphere morphology, so called ‘microstructured microspheres’. The viability of L-929 cells in the presence of sintered microspheres was 85%. The adsorption efficiencies for alendronate varied from 27.2% to 84.1% depending on the loading conditions. For BMP-2 loading, 79.2% was absorbed on the microspheres when a BMP-2 concentration of 25 μg/ml was used.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Orthodontics and Dentofacial Orthopedics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (16)
Show source-provided references
1. A new bioerodible system for sustained local drug delivery based on hydrolytically activated in situ macromolecular association10.1016/j.ijpharm.2009.09.005 ↗
2. Development of new localized drug delivery system based on ceftriaxone-sulbactam composite drug impregnated porous hydroxyapatite: a systematic approach for in vitro and in vivo animal trial10.1007/s11095-010-0166-y ↗
3. On the absorption of alendronate in rats10.1002/jps.2600831218 ↗
4. Clinical pharmacology of alendronate sodium10.1007/BF01623002 ↗
5. Effects of two oral doses of alendronate in the treatment of Paget's disease of bone10.1016/8756-3282(94)90818-4 ↗
6. A novel PHBV/HA microsphere releasing system loaded with alendronate10.1016/j.msec.2009.05.015 ↗
7. Enhancing alendronate release from a novel PLGA/Hydroxyapatite microspheric system for bone repairing applications10.1007/s11095-008-9759-0 ↗
8. In situ fabrication of alendronate-loaded calcium phosphate microspheres: controlled release for inhibition of osteoclastogenesis10.1016/j.jconrel.2010.06.016 ↗
9. Third-generation biomedical materials10.1126/science.1067404 ↗
10. New bone formation around porous hydroxyapatite wedge implanted in opening wedge high tibial osteotomy in patients with osteoarthritis10.1016/S0142-9612(00)00318-5 ↗
11. The fabrication of nano-hydroxyapatite on PLGA and PLGA/collagen nanofibrous composite scaffolds and their effects in osteoblastic behavior for bone tissue engineering10.1016/j.bone.2009.03.674 ↗
12. Ultrastructure of regenerated bone mineral surrounding hydroxyapatite-alginate composite and sintered hydroxyapatite10.1016/j.bone.2011.10.022 ↗
13. A window on biomineralization10.1126/science.1109440 ↗
14. Korea Food & Drug Administration, 2011-58; 2011 .
15. Biosphosphonates: a review of their pharmacokinetic properties10.1016/8756-3282(95)00445-9 ↗
16. Composite nanocrystals provide new insight on alendronate interaction with hydroxyapatite structure10.1002/adma.200602497 ↗